Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cuno is a global leader in the design and manufacture of filtration and purification systems, primarily serving the biopharmaceutical, healthcare, and industrial sectors. The company provides critical technologies for the separation and clarification of liquids and gases, which are essential in the production of vaccines, monoclonal antibodies, and other biologics. Its product portfolio includes depth filters, membrane filters, and high-performance housings used in sterile filtration and downstream processing. Acquired by 3M in 2005 for approximately $1.35 billion, Cuno now operates as a key component of 3M's Separation and Purification Sciences Division. The company's solutions are widely utilized by major pharmaceutical firms to ensure product purity and process efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CUNO.